Aceto Corporation Announces Rising Pharmaceuticals Subsidiary Launches Generic Version of Ancobon Capsules And Aralen Tablets

Aceto Corporation announced that Rising Pharmaceuticals Inc., its generic finished dosage form subsidiary, has launched the 250 mg and 500 mg strengths of Flucytosine Capsules, the first approved generic version of Valeant Pharmaceuticals International's Ancobon Capsules, and 500 mg strength of Chloroquine Phosphate Tablets, an approved generic version of Sanofi Aventis US's Aralen Tablets, following the U.S. Food and Drug Administration (FDA) approval of both Abbreviated New Drug Applications (ANDA's).